Reassessing Renal Artery Stenting and Sacubitril/ Valsartan Use in Hemodialysis patients: A Critical Review
Abstract: This article critically evaluates the use of renal artery stenting and sacubitrilvalsartan in hemodialysis patients. It explores the risks and benefits, considering recent studies and clinical trials. The focus is on the potential impact on patient outcomes, particularly in managing renovascular hypertension and cardiovascular complications associated with chronic kidney disease.
Keywords: Renal Artery Stenting, SacubitrilValsartan, Hemodialysis, Renovascular Hypertension, Chronic Kidney Disease
How to Cite?: Ljiljana Fodor Duric, "Reassessing Renal Artery Stenting and Sacubitril/ Valsartan Use in Hemodialysis patients: A Critical Review", Volume 12 Issue 11, November 2023, International Journal of Science and Research (IJSR), Pages: 2123-2124, https://www.ijsr.net/getabstract.php?paperid=SR231128155130, DOI: https://dx.doi.org/10.21275/SR231128155130